Feb 9 (Reuters) - Indian drugmaker Aurobindo Pharma reported a 7.6% rise in profit on Monday, helped by steady domestic demand, especially for its anti-retroviral drugs for HIV infections.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

MUMBAI- Amway India’s losses widened further in FY25 as it reported a total loss of Rs 74.25 crore for the financial year ended March 31, 2025, compared with a loss of Rs 53.38 crore in the previous ...